The DOI matches its Crossref record.
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Abstract
Interleukin-6 (IL-6) is a multifunctional cytokine that regulates various aspects of the immune response, acute-phase reaction and haematopoiesis (for reviews see refs 1, 2). In vitro, leukaemia inhibitory factor, oncostatin M, ciliary neurotrophic factor and interleukin-11 display overlapping activities with IL-6. This functional redundancy may be explained by the interactions of specific binding receptors with a common signal-transducing receptor (gp130) (for reviews see refs 3, 4). To elucidate the unique function of IL-6 in vivo, we have disrupted the IL-6 gene by homologous recombination. IL-6-deficient mice develop normally. They fail to control efficiently vaccinia virus and infection with Listeria monocytogenes, a facultative intracellular bacterium. The T-cell-dependent antibody response against vesicular stomatitis virus is impaired. Further, the inflammatory acute-phase response after tissue damage or infection is severely compromised, whereas it is only moderately affected after challenge with lipopolysaccharide. We conclude that IL-6 production induced by injury or infection is an important in vivo SOS signal which coordinates activities of liver cells, macrophages and lymphocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, a certain amount of IL-6 is required for efficient immune defense (Kopf et al., 1994) and liver regeneration (Cressman et al., 1996; Sakamoto et al., 1999; Zimmers et al., 2003).”
From Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor Ruxolitinib (2017) · cites this paper as Kopf et al., 1994
In the citing paper
“IL-6 is a critical inducer of the acute phase (AP) response in the liver, 11”
From Interleukin 6 Is Important for Survival After Partial Hepatectomy in Mice (2003) · cites this paper as [11]
In the citing paper
“IL-6 transgenic mice show severe plasmacytosis with hypergammaglobulinemia (147), while IL-6-deficient mice are defective in immunoglobulin production (148, 149).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [148]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 30
- Van-Snick, J. A. Rev. Immun. 8, 253–278 (1990). · DOI · Paper page
- Kishimoto, T. Blood 74, 1–10 (1989). · DOI
- Kishimoto, T., Akira, S. & Taga, T. Science 258, 593–597 (1992). · DOI · Paper page
- Stahl, N. & Yancopolous, G. D. Cell 74, 587–590 (1993). · DOI
- Rothstein, J. L. et al. Genes Dev. 6, 1190–1201 (1992). · DOI
- Lotz, M. et al. J. exp. Med. 167, 1253–1258 (1988). · DOI
- Uyttenhove, C., Coulie, P. G. & Van, S. J. J. exp. Med. 167, 1417–1427 (1988). · DOI
- Gupta, S. L., Hengartner, H. & Zinkernagel, R. Proc. natn. Acad. Sci. U.S.A. 82, 2604–2608 (1986). · DOI
- Suematsu, S. et al. Proc. natn. Acad. Sci. U.S.A. 86, 7547–7551 (1989). · DOI · Paper page
- Leist, T. P., Kohler, M. & Zinkernagel, R. M. Scand. J. Immun. 30, 679–686 (1989). · DOI
- Doherty, P. C., Allan, W. & Eichelberger, M. A. Rev. Immun. 10, 123–151 (1992). · DOI
- Spriggs, M. K. et al. Proc. natn. Acad. Sci. U.S.A. 89, 6070–6074 (1992). · DOI
- Huang, S. et al. Science 259, 1742–1745 (1993). · DOI
- Ramsay, A. J., Ruby, J. & Ramshaw, I. A. Immun. Today 14, 155–157 (1993). · DOI
- Kaufmann, S. A. Rev. Immun. 11, 129–163 (1993). · DOI
- Liew, F. Y. & Cox, F. E. G. Immunoparasit. Today A17–A21 (1991). · DOI
- Beckerman, K. P. et al. J. Immun. 150, 888–895 (1993). · DOI
- Gregory, S. H., Wing, E. J., Hoffman, R. A. & Simmons, R. L. J. Immun. 150, 2901–2909 (1993). · DOI
- North, R. J. J. Immun. 121, 806–810 (1978). · DOI
- Dalton, D. K. et al. Science 259, 1739–1742 (1993). · DOI
- Pfeffer, K. et al. Cell 73, 457–467 (1993). · DOI · Paper page
- Rothe, J. et al. Nature 364, 798–802 (1993). · DOI
- Havel, E. A., Moldawer, L. L., Helfgott, D., Kilian, P. L. & Sehgal, P. B. J. Immun. 148, 1486–1492 (1992). · DOI
- Koj, A. in Injury and Infection (eds Gordon, A. H. & Koj, A.) 145–160 (Elsevier, Amsterdam, 1985).
- Van Snick, J. et al. Proc. natn. Acad. Sci. U.S.A. 83, 9679–9683 (1986). · DOI
- Binder, D. & Kundig, T. M. J. Immun. 146, 4301–4307 (1991). · DOI
- Blanden, R. V. & Langmann, R. E. Scand. J. Immun. 1, 379–391 (1972). · DOI
- Ding, A. H., Nathan, C. F. & Stuehr, J. Immun. 141, 2407–2412 (1988). · DOI
- Baumann, H., Latimer, J. J. & Glibetic, M. D. Arch. Biochem. Biophys. 246, 488–493 (1986). · DOI
- Baumann, H. Meth. Enzym. 163, 566–594 (1988). · DOI
Cited by
Sorted by citations
Items 801–900 of 1,005
Identification of IL6 as a susceptibility gene for major depressive disorder
Zhang, C., Wu, Z., Zhao, G., Wang, F., & Fang, Y. (2016) · Scientific Reports · doi:10.1038/srep31264 · Cited by 46
Neoh, C. F., Chen, S. C. ‐., Lanternier, F., Tio, S. Y., Halliday, C. L., Kidd, S. E., Kong, D. C. M., Meyer, W., Hoenigl, M., & Slavin, M. A. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00004-23 · Cited by 53
Antitumoral Cascade-Targeting Ligand for IL-6 Receptor-Mediated Gene Delivery to Glioma.
Wang, S., Reinhard, S., Li, C., Qian, M., Jiang, H., Du, Y., Lächelt, U., Lu, W.-Y., Wagner, E., & Huang, R.-Q. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.04.023 · Cited by 46
“The natural ligand of IL-6R is interleukin-6 (IL-6), a member of the inflammatory cytokine family, which was initially described as a central mediator of the immune system, hematopoiesis, and inflammation.(12,13) Furthermore, it is well established that the interaction of IL-6 and IL-6R triggers a biological activity,…”
BackgroundLangdon, J. M., Yates, S. C., Femnou, L. K., McCranor, B. J., Cheadle, C., Xue, Q., Vaulont, S., Civin, C. I., Walston, J. D., & Roy, C. N. (2014) · American Journal of Hematology · doi:10.1002/ajh.23670 · Cited by 40
“129S2-Il6tm1Kopf/J mice [24], abbreviated here “IL-6 (2/2),” were derived from founders purchased from the Jackson Laboratories (stock 2650).”
BackgroundMethodResultGiralt, M., Ramos, R., Quintana, A., Ferrer, B., Erta, M., Castro-Freire, M., Comes, G., Sanz, E., Unzeta, M., Pifarré, P., et al. (2013) · Glia · doi:10.1002/glia.22457 · Cited by 46
“Breeding pairs of IL-6 KO mice (Kopf et al., 1994) on the C57BL/6 genetic background were provided by Dr. Horst Bluethman, Roche Center for Medical Genomics, Switzerland.”
MethodInfluentialSegundo, F. D.-S., Weiss, M., Pérez-Martín, E., Dias, C. C. A., Grubman, M. J., & Santos, T. D. L. (2011) · Journal of Virology · doi:10.1128/jvi.05941-11 · Cited by 45
“Although IL-6 does not have any known antiviral activity (47), its involvement in viral pathogenesis of vaccinia virus (44) or herpes simplex virus type 1 (54) has been demonstrated.”
BackgroundInhibition of pro-inflammatory mediators: role of Bacopa monniera (L.) Wettst
Viji, V., & Helen, A. (2011) · InflammoPharmacology · doi:10.1007/s10787-010-0046-4 · Cited by 46
Personnic, N., Bruck, S., Nahori, M., Toledo-Arana, A., Nikitas, G., Lecuit, M., Dussurget, O., Cossart, P., & Bierne, H. (2010) · Infection and Immunity · doi:10.1128/iai.01096-09 · Cited by 46
Kamperschroer, C., & Quinn, D. (2002) · Journal of Immunology · doi:10.4049/jimmunol.169.1.340 · Cited by 46
“129S6Il6 (IL-6 / ) (27), or B6;129SIl1r1 (ILDepartment of Microbiology and Immunology, Loyola University Chicago Medical Center, Maywood, IL 60153”
BackgroundA Role for Interleukin-6 in Parathyroid Hormone-Induced Bone Resorption in Vivo
Grey, A. B., Mitnick, M., MASIUKIEWICZ, U. S., Sun, B., Rudikoff, S., Jilka, R. L., Manolagas, S. C., & Insogna, K. L. (1999) · Endocrinology · doi:10.1210/endo.140.10.7036 · Cited by 169
Grob, P., Schijns, V., van den Broek, M. F., Cox, S., Ackermann, M., & Suter, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4748-4754.1999 · Cited by 46
“Therefore, our data suggest that the control of gE(2)TK(2)PRV replication by the IFN-g system was due either to its direct local antiviral effect or, indirectly, to the induction of proinflammatory cytokines such as IL-6 or a combination of both (20).”
BackgroundAndersson, Å., Grunewald, S. M., Duschl, A., Fischer, A., & Santo, J. P. D. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270725 · Cited by 31
Efficient immunity against Leishmania major in the absence of interleukin-6
Moskowitz, N., Brown, D., & Reiner, S. L. (1997) · Infection and Immunity · doi:10.1128/iai.65.6.2448-2450.1997 · Cited by 46
“IL-6-deficient mice (12) (Jackson Laboratory, Bar Harbor, Maine) were bred to wild-type mice.”
BackgroundMoradian, N., Gouravani, M., Salehi, M. A., Heidari, A., Shafeghat, M., Hamblin, M. R., & Rezaei, N. (2020) · European Cytokine Network · doi:10.1684/ecn.2020.0451 · Cited by 60
“Bringing adaptive immunity into consideration, IL-6 stimulates the transformation of immature B cells into antibodyproducing plasma cells [81].”
BackgroundFernández-Ruiz, M., López-Medrano, F., Asín, M. P. P.-J., de la Calle, G. M., Bueno, H., Caro-Teller, J., Catalán, M., de la Calle, C., García-García, R., Gómez, C., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26308 · Cited by 45
“In addition to its proinflammatory activity, IL‐6 plays a role in mounting adaptive T‐cell and humoral responses.(27) It could be hypothesized that the sequential blockade of IL‐6 signaling in the setting of ongoing IFN‐β therapy and absence of effective antiviral treatment would abrogate immune control of SARS‐CoV‐2…”
BackgroundSulfatide Attenuates Experimental Staphylococcus aureus Sepsis through a CD1d-Dependent Pathway
Kwiecinski, J., Rhost, S., Löfbom, L., Blomqvist, M., Månsson, J., Cardell, S., & Jin, T. (2013) · Infection and Immunity · doi:10.1128/iai.01334-12 · Cited by 45
“Also, IL-6 deficiency leads to impaired immune responses against both viral and bacterial infection (42).”
BackgroundKurtz, S., Foreman, O., Bosio, C., Anver, M., & Elkins, K. (2012) · Infection and Immunity · doi:10.1128/iai.01249-12 · Cited by 45
“These proteins are part of the acute-phase response, a set of early physiological reactions to injury, trauma, or infection (29, 39, 40).”
BackgroundIL-6 activates STAT5 in T cells.
Tormo, A., Letellier, M., Sharma, M., Elson, G., Crabé, S., & Gauchat, J. (2012) · Cytokine · doi:10.1016/j.cyto.2012.07.002 · Cited by 45
Parathyroid Hormone Mediates Hematopoietic Cell Expansion through Interleukin-6
Pirih, F. Q., Michalski, M. N., Sun, C. W., Koh, A., Berry, J., Ghaname, E., Kamarajan, P., Bonnelye, E., Ross, C., Kapila, Y., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013657 · Cited by 45
“Wild-type (Jackson Laboratory, Bar Harbor, ME, USA) and IL-6 deficient [19] (kindly provided by Evan Keller, University of Michigan, Ann Arbor, MI, USA) C57B6 mice at 4–8 wks of age were used for ex vivo experiments.”
MethodMurphy, E. A., Davis, J. M., Brown, A. S., Carmichael, M. D., Ghaffar, A., & Mayer, E. P. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2007.0103 · Cited by 47
d'Hauterive, S. P., Charlet-Renard, C., Dubois, M., Berndt, S., Goffin, F., Foidart, J., & Geenen, V. (2005) · Neuroimmunomodulation · doi:10.1159/000084848 · Cited by 45
Effect of 6-Hydroxydopamine on Host Resistance against Listeria monocytogenes Infection
Miura, T., Kudo, T., Matsuki, A., Sekikawa, K., Tagawa, Y., Iwakura, Y., & Nakane, A. (2001) · Infection and Immunity · doi:10.1128/iai.69.12.7234-7241.2001 · Cited by 45
“IFN- (4, 19), TNF- (16, 30, 34, 38), IL-1 (17), and IL-6 (23) reportedly play important roles in antilisterial resistance.”
BackgroundInfluentialExpression of IL-6 and IL-6 receptors by circulating clonotypic B cells in multiple myeloma
Szczepek, A. J., Belch, A. R., & Pilarski, L. M. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00682-8 · Cited by 40
Carrasco, J., Hernández, J., Bluethmann, H., & Hidalgo, J. (1998) · Brain Research. Molecular Brain Research · doi:10.1016/s0169-328x(98)00087-4 · Cited by 45
Self-citationThe function of the soluble IL-6 receptor in vivo.
Peters, M., Büschenfelde, K.-H. M. Z., & Rose-John, S. (1996) · Immunology Letters · doi:10.1016/s0165-2478(96)02669-7 · Cited by 45
Immunogenetic aspects of primary IgA nephropathy.
Schena, F. P. (1995) · Kidney International · doi:10.1038/ki.1995.503 · Cited by 45
Metabolites Associated With Circulating Interleukin-6 in Older Adults
Lustgarten, M. S., & Fielding, R. A. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw039 · Cited by 44
“When considering that AhR activation increases IL-6 expression (60) and that control of bacterial and viral infections requires IL-6 (61), these data collectively suggest a role for AhR activation, CYP1A expression, and IL-6 on mechanisms related to counteracting an increased infectious burden in older adults.”
BackgroundPrecision medicine in sepsis and septic shock: From omics to clinical tools
Ruiz‐Rodríguez, J. C., Plata-Menchaca, E. P., Chiscano‐Camón, L., Ruiz-Sanmartín, A., Pérez-Carrasco, M., Palmada, C., Ribas, V. J., Martínez‐Gallo, M., Hernández-González, M., González‐López, J. J., et al. (2022) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v11.i1.1 · Cited by 49
IL-6 is produced by adipose-derived stromal cells and promotes osteogenesis
Huh, J.-E., & Lee, S. Y. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.025 · Cited by 52
“Interleukin-6 (IL-6) is a pleiotropic cytokine that regulates immune responses, acute phase reactions, and hematopoiesis and may play a central role in host defense mechanisms [13].”
BackgroundMyskiw, C., Arsenio, J., Hammett, C., van Bruggen, R., Deschambault, Y., Beausoleil, N., Babiuk, S., & Cao, J. (2011) · Journal of Virology · doi:10.1128/jvi.05505-11 · Cited by 44
O’Gorman, W. E., Sampath, P., Simonds, E. F., Sikorski, R. P., O’Malley, M. E., Krutzik, P. O., Chen, H., Panchanathan, V., Chaudhri, G., Karupiah, G., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.07.008 · Cited by 33
“The ability of IL-6 to promote antibody production is well-established (Kopf et al., 1994, 1998; Suematsu et al., 1989).”
BackgroundInterleukin-6 Expression after Infectious Bronchitis Virus Infection in Chickens
Asif, M., Lowenthal, J. W., Ford, M. E., Schat, K. A., Kimpton, W. G., & Bean, A. G. D. (2007) · Viral Immunology · doi:10.1089/vim.2006.0109 · Cited by 41
Yeh, C.-L., Hsu, C., Yeh, S.-L., & Chen, W.-J. (2005) · Cytokine · doi:10.1016/j.cyto.2005.06.001 · Cited by 44
“and acute-phase responses in mice [8].”
Effect of leukocytapheresis therapy using a leukocyte removal filter in Crohn's disease.
Kosaka, T., Sawada, K., Ohnishi, K., Egashira, A., Yamamura, M., Tanida, N., Satomi, M., & Shimoyama, T. (1999) · Internal medicine · doi:10.2169/internalmedicine.38.102 · Cited by 44
IL-6 as a drug discovery target
Stein, B., & Sutherland, M. K. (1998) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01164-1 · Cited by 42
Influence of interleukin‐6 (IL‐6) autoantibodies on IL‐6 binding to cellular receptors
Hansen, M., Svenson, M., Abell, K., Yasukawa, K., Diamant, M., & Bendtzen, K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250207 · Cited by 44
Single‐cell transcriptomics reveals a senescence‐associated IL‐6/CCR6 axis driving radiodermatitis
Paldor, M., Levkovitch‐Siany, O., Eidelshtein, D., Adar, R., Enk, C. D., Marmary, Y., Elgavish, S., Nevo, Y., Benyamini, H., Plaschkes, I., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202115653 · Cited by 46
Serotonin synthesis protects the mouse colonic crypt from DNA damage and colorectal tumorigenesis
Sakita, J. Y., Bäder, M., Santos, E. D. S., Garcia, S. B., Minto, S. B., Alenina, N. V., Brunaldi, M. O., de Carvalho, M. C., Vidotto, T., Gasparotto, B., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5285 · Cited by 49
“Tph1 and Il6 double knockout mice (Tph1-Il6DKO) were bred according to see supplementary material, Figure S1 and genotyped as described previously [19,22].”
MethodRops, A. L. W. M. M., Jansen, E., van der Schaaf, A., Pieterse, E., Rother, N., Hofstra, J. M., Dijkman, H. B. P. M., van de Logt, A.-E., Wetzels, J. F. M., van der Vlag, J., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.01.005 · Cited by 42
Ijaz, T., Tilton, R., & Brasier, A. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.06.37 · Cited by 43
“Surprisingly, IL-6 deficiency does not alter mature numbers of macrophages in vivo, but does make IL-6-/- mice succumb to infections by Listeria monocytogenes—a bacterium that survives and proliferates in macrophages (43).”
BackgroundCytokines and persistent viral infections
Beltra, J., & Decaluwe, H. (2016) · Cytokine · doi:10.1016/j.cyto.2016.02.006 · Cited by 51
Quintana, A., Molinero, A., Borup, R., Nielsen, F., Campbell, I., Penkowa, M., & Hidalgo, J. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20584 · Cited by 43
“Depending on the injury model, IL6 KO animals show a compromised inflammatory response, gliosis, and specific neuronal survival (Kopf et al., 1994; Penkowa et al., 1999; Murphy et al., 2000; Swartz et al., 2001; Poulsen et al., 2005).”
Yang, X., Schaper, F., Teubner, A., Lammert, F., Heinrich, P. C., Matern, S., & Siewert, E. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.048 · Cited by 41
Interleukin-6 Gene Ablation in a Transgenic Mouse Model of Malignant Skin Melanoma
von Felbert, V., Córdoba, F. M., Weissenberger, J., Vallan, C., Kato, M., Nakashima, I., Braathen, L. R., & Weis, J. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62304-8 · Cited by 37
“To analyze the contribution of IL-6 to the development and progression of melanomas in MT-ret mice, we crossed these mice with IL-6-deficient animals.(37) We report here that ablation of IL-6 leads to a reduction in tumor incidence and tumor size in this model of spontaneous melanoma.”
BackgroundMethodAshino, T., Oguro, T., Shioda, S., Horai, R., Asano, M., Sekikawa, K., Iwakura, Y., Numazawa, S., & Yoshida, T. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.7.707 · Cited by 39
“The IL-1 / KO mice were established by Horai et al. (1998), the TNF KO mice were established by Tagawa et al. (1997), and the IL-6 KO mice were established by Kopf et al. (1994).”
Methodvan de Loo, F. V. D., Arntz, O., & van den Berg, W. (1997) · Cytokine · doi:10.1006/cyto.1997.0188 · Cited by 43
Interleukin‐10 Directly Inhibits the Interleukin‐6 Production in T‐Cells
Hempel, L., Körholz, D., Bonig, H., Schneider, M., Klein-Vehne, A., Packeisen, J., Mauz-Körholz, C., & Burdach, S. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03593.x · Cited by 43
The role of cytokines and neuroendocrine hormones in cutaneous immunity and inflammation
Luger, T., & Schwarz, T. (1995) · Allergy. European Journal of Allergy and Clinical Immunology · doi:10.1111/j.1398-9995.1995.tb01151.x · Cited by 43
Molecular Analysis of DNA Rearrangements in the Immune System
Jessberger, R., & Lieber, M. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-50140-1 · Cited by 43
Rethinking interleukin-6 blockade for treatment of COVID-19
Scherger, S., Henao-Martínez, A., Franco-Paredes, C., & Shapiro, L. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110053 · Cited by 42
“These IL-6 KO mice also demonstrated increased susceptibility to Listeria monocytogenes infection, possibly due to reduced bactericidal activity of macrophages [11].”
Klemm, C., Bruchhagen, C., van Krüchten, A., Niemann, S., Löffler, B., Peters, G., Ludwig, S., & Ehrhardt, C. (2017) · Scientific Reports · doi:10.1038/srep42473 · Cited by 46
“In contrast, the serum levels of the APP SAA and mRNA levels of ORM , whose expression is strongly dependent on IL-6 in mice and humans 28,29 , were significantly enhanced after super-infection compared to IV-infected mice (Fig.”
Saquib, Q., Siddiqui, M., Ahmed, J., Al-Salim, A., Ansari, S. M., Faisal, M., Al-khedhairy, A., Musarrat, J., Alwathnani, H., Alatar, A., et al. (2016) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2016.01.025 · Cited by 42
Sato, S., Richard, M. L., Brandon, D., Buie, J. N. J., Oates, J. C., Gilkeson, G. S., & Zhang, X. K. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38818 · Cited by 40
Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis
Loppnow, H., Buerke, M., Werdan, K., & Rose‐John, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01245.x · Cited by 39
“Among the secondary cytokines produced in response to IL-1 or TNF- IL-6 is of major interest, because this cytokine is an important activator of the acute phase response [77].”
BackgroundExpression and self-regulatory function of cardiac interleukin-6 during endotoxemia
Saitō, H., Patterson, C., Hu, Z., Runge, M. S., Tipnis, U. R., Sinha, M., & Papaconstantinou, J. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.5.h2241 · Cited by 41
The intestine: A highly dynamic microenvironment for IgA plasma cells
Pracht, K., Wittner, J., Kagerer, F., Jäck, H., & Schuh, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1114348 · Cited by 44
Shih, P.-Y., Fang, Y.-L., Shankar, S., Lee, S., Hu, H., Chen, H., Wang, T., Hsia, K., & Hsueh, Y. (2022) · Nature Communications · doi:10.1038/s41467-022-30353-0 · Cited by 41
Cho, S., Pirih, F. Q., Koh, A., Michalski, M. N., Eber, M. R., Ritchie, K., Sinder, B., Oh, S., Al‐Dujaili, S. A., Lee, J., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.393363 · Cited by 41
“C57B6 IL-6 / mice (25) were kindly provided by Evan Keller (University of Michigan, Ann Arbor, MI), and breeding was established to generate desired genotypes.”
MethodKumpf, O., & Schumann, R. R. (2010) · Journal of Innate Immunity · doi:10.1159/000314269 · Cited by 40
“In conclusion, according to the animal knockout data, the role of the IL-1 family in sepsis, SIRS and CARS apparently is complex: while IL-1 seems to mediate effects contributing to lethality, other members of this family, as shown by the experiments with the IL-1R knockout mice, seem to also play a protective role du…”
BackgroundAguilar‐Valles, A., Poole, S., Mistry, Y., Williams, S., & Luheshi, G. N. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.132829 · Cited by 44
“As mentioned earlier, LPS is capable of stimulating several organs to produce fever mediators that act in a highly redundant fashion, as is further evidenced by the lack of effect of targeted mutations (‘knock out’) of cytokines on LPS-febrile response (Kopf et al. 1994; Zheng et al. 1995; Kozak et al. 1997; Leon, 200…”
BackgroundKagiwada, K., Dai, C.-D., Sakatani, T., Asano, M., Nambu, A., Kakuta, S., & Iwakura, Y. (2004) · Endocrinology · doi:10.1210/en.2004-0054 · Cited by 41
The therapeutic potential of interleukin-6 in treating obesity
Wallenius, K., Jansson, J., & Wallenius, V. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.7.1061 · Cited by 41
“In one of the first articles describing IL-6 knockout mice, Kopf and co-workers showed that endogenous IL-6 is essential for the immune response to certain intracellular pathogens, such as Listeria monocytogenes, and viruses, for example, vaccinia [22].”
BackgroundOn the site and mechanism of action of the anti-obesity effects of interleukin-6
Jansson, J., Wallenius, K., Asterholm, I. W., Ohlsson, C., Dickson, S. L., & Wallenius, V. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00051-0 · Cited by 34
Hilbert, D. M., Migone, T.-S., Kopf, M., Leonard, W. J., & Rudikoff, S. (1996) · Immunity · doi:10.1016/s1074-7613(00)80312-x · Cited by 40
Self-citationCancer-Associated Cachexia: A Systemic Consequence of Cancer Progression
Biswas, A., & Acharyya, S. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033642 · Cited by 42
“Still, it is important to consider that sustained blockade in IL-6 signaling can increase the risk of infection from neutropenia and result in compensatory increases in the activity of other proinflammatory cytokines (Kopf et al. 1994).”
BackgroundAnti-IL6 Autoantibodies in an Infant With CRP-Less Septic Shock
Bloomfield, M., Paračková, Z., Cabelova, T., Pospíšilová, I., Kabícek, P., Houšt'ková, H., & Šedivá, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02629 · Cited by 50
“Additionally, an IL-6 knockout murine model was shown to develop normally, but the inflammatory acutephase response after tissue damage or infection was severely compromised (14).”
BackgroundYe, G., Yin, G., Tang, Z., Fu, J. L., Chen, J., Chen, S. S., Li, J., Fu, T., Yu, X., Xu, D. W., et al. (2018) · Psychological Medicine · doi:10.1017/s0033291718000090 · Cited by 47
“Interleukin 6 (IL-6) is a multifunctional cytokine that regulates the growth and differentiation of various cells and plays a critical role in immune response and acute phase reactions (Kopf et al. 1994; Kiecolt-Glaser et al. 2003).”
BackgroundMeasles virus nucleocapsid protein increases osteoblast differentiation in Paget’s disease
Teramachi, J., Nagata, Y., Mohammad, K. S., Inagaki, Y., Ohata, Y., Guise, T. A., Michou, L., Brown, J. P., Windle, J. J., Kurihara, N., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82012 · Cited by 46
Blaho, V., Buczynski, M. W., Dennis, E., & Brown, C. R. (2009) · Journal of Immunology · doi:10.4049/jimmunol.0901499 · Cited by 40
“IL-6° mice infected with B. burgdorferi, Listeria monocytogenes, or vesicular stomatitis virus, among others, have significantly lowered serum levels of Ag-specific IgG (55, 56).”
BackgroundOzone modulates IL-6 secretion in human airway epithelial and smooth muscle cells.
Damera, G., Zhao, H., Wang, M., Smith, M., Kirby, C., Jester, W., Lawson, J., & Panettieri, R. (2009) · American Journal of Physiology - Lung cellular and Molecular Physiology · doi:10.1152/ajplung.90585.2008 · Cited by 40
“suggest a protective role of IL-6 (38).”
Geisel, J., Kahl, F., Müller, M., Wagner, H., Kirschning, C. J., Autenrieth, I. B., & Frick, J.-S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5811 · Cited by 64
“Naive DC were prepared from IL-6 / mice (21) and stimulated as described above.”
BackgroundMethodAlonzi, T., Gorgoni, B., Screpanti, I., Gulino, A., & Poli, V. (1997) · Immunobiology · doi:10.1016/s0171-2985(97)80035-6 · Cited by 40
Ciapponi, L., Maione, D., Scoumanne, A., Costa, P., Hansen, M. B., Svenson, M., Bendtzen, K., Alonzi, T., Paonessa, G., Cortese, R., et al. (1997) · Nature Biotechnology · doi:10.1038/nbt1097-997 · Cited by 39
A new hepatocyte stimulating factor: cardiotrophin‐1 (CT‐1)
Peters, M., Roeb, E., Pennica, D., zum Büschenfelde, K.-H. M., & Rose-John, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00972-c · Cited by 39
Investigating the epigenetic profile of the inflammatory gene IL-6 in late-life depression
Ryan, J. L., Pilkington, L., Neuhaus, K., Ritchie, K. A., Ancelin, M., & Saffery, R. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1515-8 · Cited by 41
“It plays a major role during the immune response and acute-phase reaction [11].”
BackgroundSzot, P., Franklin, A., Figlewicz, D., Beuca, T. P., Bullock, K. M., Hansen, K., Banks, W., Raskind, M., & Peskind, E. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.04.028 · Cited by 39
Malchow, S., Thaiss, W. M., Jänner, N., Waetzig, G. H., Gewiese, J., Garbers, C., Yamamoto, K., Rose‐John, S., & Scheller, J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.11.009 · Cited by 39
Hohenstein, B., Kuo, M.-C., Addabbo, F., Yasuda, K., Ratliff, B., Schwarzenberger, C., Eckardt, K., Hugo, C., & Goligorsky, M. (2010) · AJP - Renal Physiology · doi:10.1152/ajprenal.00025.2010 · Cited by 39
“In contrast, IL-6 and -10 as well as MCP-1 are much more prominent mediators of the inflammatory response upon endothelial injury (42, 43) but have also been linked to some extent with the regulation of progenitor cell activity (29) and endothelial repair (11).”
BackgroundWuestefeld, T., Klein, C., Streetz, K., Beraza, N., Schölmerich, J., Burgart, L., Zender, L., Kubicka, S., Gores, G., Manns, M., et al. (2005) · Hepatology · doi:10.1002/hep.20912 · Cited by 39
Viral IL-6 Blocks Neutrophil Infiltration during Acute Inflammation1
Fielding, C., McLoughlin, R., Colmont, C. S., Kovaleva, M., Harris, D., Rose-John, S., Topley, N., & Jones, S. A. (2005) · Journal of Immunology · doi:10.4049/jimmunol.175.6.4024 · Cited by 39
“0 3,639 1,417 10,847 2,652 50 6,342 1,851 13,686 3,209 (13,550) 100 7,426 1,728 15,664 2,142 (14,634) 250 10,140 1,779* 17,722 2,749 (17,348) 500 10,436 1,144*** 19,869 3,082* (17,644)”
Cao, L., & Lawrence, D. A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00371-5 · Cited by 41
“129 background) without stress showed decreased host resistance to LM (Kopf et al., 1994), Chlamydia trachomatis (Williams et al.”
BackgroundKlein, B., Seckinger, A., Moehler, T. M., & Hose, D. (2011) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-85772-3_3 · Cited by 38
Zhao, M., Wang, M., Chen, X., Gao, Y., Chen, Q., Wang, L., Bao, Q., Sun, D., Du, W., Xu, Y., et al. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.133199 · Cited by 39
Zhang, X.-S., Shen, Y.-B., Xu, X.-Y., Zhang, M., Bai, Y.-L., Miao, Y.-F., Fang, Y., Zhang, J.-H., Wang, R.-Q., & Li, J.-L. (2018) · Fish and Shellfish Immunology · doi:10.1016/j.fsi.2018.09.047 · Cited by 38
Tvedt, T. H., Lie, S., Reikvam, H., Rye, K. P., Lindås, R., Gedde-Dahl, T., Ahmed, A., & Bruserud, Ø. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111823 · Cited by 38
“Mice depleted of IL-6 still retain their ability to produce CRP [16].”
BackgroundIL‐6 regulates exercise and training‐induced adaptations in subcutaneous adipose tissue in mice
Brandt, C., Jakobsen, A. H., Adser, H., Olesen, J., Iversen, N., Kristensen, J. M., Hojman, P., Wojtaszewski, J., Hidalgo, J., & Pilegaard, H. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02373.x · Cited by 38
“2002), and it has been demonstrated that serum IL-6 is undetectable in IL-6 KO mice even after an LPS injection (Kopf et al. 1994).”
BackgroundShao, R., Nutu, M., Karlsson-Lindahl, L., Benrick, A., Weijdegård, B., Lager, S., Egecioglu, E., Fernandez-Rodriguez, J., Gemzell-Danielsson, K., Ohlsson, C., et al. (2009) · American Journal of Physiology - Cell Physiology · doi:10.1152/ajpcell.00047.2009 · Cited by 38
Suh, C., Chun, H., Ye, Y.-M., & Park, H.-S. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.11.006 · Cited by 38
Lawlor, K. E., Wong, P. K. K., Campbell, I. K., van Rooijen, N., & Wicks, I. P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21495 · Cited by 36
The crucial role of systemic responses in the innate (non-adaptive) host defense
Munford, R., & Pugin, J. (2001) · Journal of Endotoxin Research · doi:10.1177/09680519010070040501 · Cited by 38
“Emergency” granulopoiesis in G-CSF–deficient mice in response to Candida albicans infection
Basu, S., HODGSON, G. S., Zhang, H., Katz, M., Quilici, C., & Dunn, A. R. (2000) · Blood · doi:10.1182/blood.v95.12.3725 · Cited by 144
Cytokine mediation of ozone-induced pulmonary adaptation.
Mckinney, W. J., Jaskot, R. H., Richards, J. H., Costa, D. L., & Dreher, K. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.5.2928 · Cited by 38
Kumanogoh, A., Marukawa, S., Kumanogoh, T., Hirota, H., Yoshida, K., Lee, I., Yasui, T., Taga, T., & Kishimoto, T. (1997) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.94.6.2478 · Cited by 38
Self-citationAnalysis of Host Immunological Response of Adenovirus-Based COVID-19 Vaccines
Farhang-Sardroodi, S., Korosec, C. S., Gholami, S., Craig, M., Moyles, I., Ghaemi, M. S., Ooi, H. K., & Heffernan, J. (2021) · medRxiv · doi:10.1101/2021.06.24.21259460 · Cited by 37
Barbierato, M., Borri, M., Facci, L., Zusso, M., Skaper, S. D., & Giusti, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-12529-7 · Cited by 38
Wang, L., Liu, P., Wan, Z. Y., Huang, S. Q., Wen, Y. F., Lin, G., & Yue, G. H. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.06.058 · Cited by 39
Pan, H., Xu, L., Huang, M.-Y., Zha, Q., Zhao, G., Hou, X.-F., Shi, Z., Lin, Q.-R., Ouyang, D., & He, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5957 · Cited by 39
“It has been known that IL-6 and TNF-α secretion by macrophages upon bacterial infection in turn enhances their phagocytic capacity, thus promoting the clearance of pathogens [31, 46, 47].”
Disrupted glucocorticoid—Immune interactions during stress response in schizophrenia
Chiappelli, J., Shi, Q., Kodi, P., Savransky, A., Kochunov, P., Rowland, L. M., Nugent, K. L., & Hong, L. E. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.09.010 · Cited by 35
“IL-6 is a pleiotropic, pro-inflammatory cytokine that is released from several immune and nonimmune cell types, and mediates acute inflammatory responses to immune challenges (Kishimoto et al 1992; Kopf et al 1994).”
BackgroundLong pentraxin PTX3 attenuates ischemia reperfusion injury in a cardiac transplantation model
Zhu, H., Cui, D., Liu, K., Wang, L., Huang, L., & Li, J. (2013) · Transplant International · doi:10.1111/tri.12197 · Cited by 36
“IL-6 is a proinflammatory cytokine that plays a key role in both innate and adaptive immune response [28], and it is essential in the induction of Th17 cells in both human and mice [29].”
BackgroundThe in vitro and in ovo responses of chickens to TLR9 subfamily ligands.
Jenkins, K., Lowenthal, J., Kimpton, W., & Bean, A. (2009) · Developmental and Comparative Immunology · doi:10.1016/j.dci.2008.11.009 · Cited by 37
Metadata
- Authors
- Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G.
- Affiliations
- University of Zurich (CH)
- Max Planck Society (DE)
- The University of Osaka (JP)
- F. Hoffmann-La Roche AG (CH)
- Roswell Park Comprehensive Cancer Center (US)
- Venue
- Nature
- Published
- 1994-03-24
- Volume
- 368
- Issue
- 6469
- Pages
- 339-342
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2067761476
- Cited by
- 1,768
- References
- 0
- Citations by year
- 2026: 20 · 2025: 33 · 2024: 23 · 2023: 36 · 2022: 44 · 2021: 58 · 2020: 43 · 2019: 52 · 2018: 46 · 2017: 60 · 2016: 57 · 2015: 44 · 2014: 48 · 2013: 56 · 2012: 64
- FWCI
- 28.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- interleukin-6, IL-6-deficient mice, gene disruption, acute phase response, immune response, vaccinia virus infection, Listeria monocytogenes, T cell-dependent antibody response, vesicular stomatitis virus, lipopolysaccharide, gp130, cytokine redundancy, inflammation, macrophages, liver
- MeSH terms
- Acute-Phase Reaction, Animals, B-Lymphocytes, Immunity, Listeriosis, Lymphoid Tissue, Mice, Inbred C57BL, RNA, Messenger, T-Lymphocytes, Vesicular stomatitis Indiana virus, Interleukin-6, Rhabdoviridae Infections, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review